Takeda Pharmaceutical (TAK) Change in Inventory (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Change in Inventory of -$209.6 million for Q2 2026, down 132.04% year-over-year from $654.2 million in Q2 2025, and down 275.76% quarter-over-quarter from $119.2 million in Q1 2026.
Takeda Pharmaceutical (TAK) Change in Inventory (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Change in Inventory history runs 9 years deep, the most recent figure standing at -$209.6 million for Q2 2026.
- In Q2 2026, Change in Inventory fell 132.04% year-over-year to -$209.6 million; the TTM figure through Jun 2026 stood at -$533.6 million (down 105.89% YoY), while the FY2026 annual figure was -$407.2 million, down 77.35% from the prior year.
- Change in Inventory for Q2 2026 stood at -$209.6 million, down from $119.2 million in the prior quarter.
- The five-year high for Change in Inventory was $139.7 million in Q4 2024, with the low at -$342.0 million in Q4 2023.
- The 5-year median for Change in Inventory is -$110.5 million (2022), against an average of -$128.4 million.
- The sharpest annual moves came in 2023 and 2026: Change in Inventory sank 608.63% in 2023, then surged 464.42% in 2026.
- Takeda Pharmaceutical's Change in Inventory stood at -$130.7 million in 2022, then sank by 161.71% to -$342.0 million in 2023, then soared by 140.85% to $139.7 million in 2024, then slumped by 276.58% to -$246.7 million in 2025, then increased by 15.04% to -$209.6 million in 2026.
- Business Quant data shows TAK's Change in Inventory at -$209.6 million in Q2 2026, $119.2 million in Q1 2026, and -$246.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | -7.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -209.58 Mn |
| Jun 30, 2026 | -209.58 Mn |
| Mar 31, 2026 | 119.24 Mn |
| Mar 31, 2026 | 119.24 Mn |
| Dec 31, 2025 | -246.67 Mn |
| Dec 31, 2025 | -246.67 Mn |
| Sep 30, 2025 | -196.56 Mn |
| Sep 30, 2025 | -196.56 Mn |
| Jun 30, 2025 | -90.32 Mn |
| Jun 30, 2025 | -90.32 Mn |
| Mar 31, 2025 | -32.72 Mn |
| Mar 31, 2025 | -32.72 Mn |
| Dec 31, 2024 | 139.69 Mn |
| Dec 31, 2024 | 139.69 Mn |
| Sep 30, 2024 | -275.80 Mn |
| Sep 30, 2024 | -275.80 Mn |
| Jun 30, 2024 | -64.75 Mn |
| Jun 30, 2024 | -64.75 Mn |
| Mar 31, 2024 | 86.01 Mn |
| Mar 31, 2024 | 86.01 Mn |